Sort by
Quarterly Activities Report and Appendix 4C
IVX: Photosoft & Novel Immunotherapy Collab Partnership
Percheron and Invion to Explore Cancer Combination Therapy
Change of Director's Interest Notice
Notice under S708A
Application for quotation of securities - PER
Application for quotation of securities - PER
Change of Director's Interest Notice
Notification regarding unquoted securities - PER
Results of Annual General Meeting
| Date | Headline |
|---|---|
20 Oct 2026 | Quarterly Activities Report and Appendix 4C |
20 Oct 2026 | IVX: Photosoft & Novel Immunotherapy Collab Partnership |
20 Oct 2026 | Percheron and Invion to Explore Cancer Combination Therapy |
15 Oct 2026 | Change of Director's Interest Notice |
15 Oct 2026 | Notice under S708A |
14 Oct 2026 | Application for quotation of securities - PER |
14 Oct 2026 | Application for quotation of securities - PER |
8 Oct 2026 | Change of Director's Interest Notice |
8 Oct 2026 | Notification regarding unquoted securities - PER |
7 Oct 2026 | Results of Annual General Meeting |
Investor presentations
Updates
Sort by